CinchonidineCAS# 485-71-2 |
- CFM 1571 hydrochloride
Catalog No.:BCC5924
CAS No.:1215548-30-3
- A 350619 hydrochloride
Catalog No.:BCC5939
CAS No.:1217201-17-6
- BAY 41-2272
Catalog No.:BCC7932
CAS No.:256376-24-6
- Riociguat
Catalog No.:BCC1899
CAS No.:625115-55-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 485-71-2 | SDF | Download SDF |
PubChem ID | 2757 | Appearance | White powder |
Formula | C19H22N2O | M.Wt | 294.39 |
Type of Compound | Nitrogen-containing Compounds | Storage | Desiccate at -20°C |
Synonyms | (-)-Cinchonidine; Cinchovatine; Alpha-Quinidine; | ||
Solubility | DMSO : 33.33 mg/mL (113.22 mM; Need ultrasonic) | ||
Chemical Name | (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-quinolin-4-ylmethanol | ||
SMILES | C=CC1CN2CCC1CC2C(C3=CC=NC4=CC=CC=C34)O | ||
Standard InChIKey | KMPWYEUPVWOPIM-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Cinchonidine Dilution Calculator
Cinchonidine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.3969 mL | 16.9843 mL | 33.9685 mL | 67.9371 mL | 84.9214 mL |
5 mM | 0.6794 mL | 3.3969 mL | 6.7937 mL | 13.5874 mL | 16.9843 mL |
10 mM | 0.3397 mL | 1.6984 mL | 3.3969 mL | 6.7937 mL | 8.4921 mL |
50 mM | 0.0679 mL | 0.3397 mL | 0.6794 mL | 1.3587 mL | 1.6984 mL |
100 mM | 0.034 mL | 0.1698 mL | 0.3397 mL | 0.6794 mL | 0.8492 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (+)-Bicuculline
Catalog No.:BCN1238
CAS No.:485-49-4
- Cytisine
Catalog No.:BCN6270
CAS No.:485-35-8
- Reticuline
Catalog No.:BCN5583
CAS No.:485-19-8
- Aristolochic acid C
Catalog No.:BCN2658
CAS No.:4849-90-5
- N-Nornuciferine
Catalog No.:BCN4048
CAS No.:4846-19-9
- ProTx II
Catalog No.:BCC6103
CAS No.:484598-36-9
- ProTx I
Catalog No.:BCC6255
CAS No.:484598-35-8
- Brucine sulfate
Catalog No.:BCN2460
CAS No.:4845-99-2
- DPH
Catalog No.:BCC1538
CAS No.:484049-04-9
- Okanin
Catalog No.:BCN6475
CAS No.:484-76-4
- Isodictamnine
Catalog No.:BCN7066
CAS No.:484-74-2
- Angiotensin I (human, mouse, rat)
Catalog No.:BCC1004
CAS No.:484-42-4
- Formononetin
Catalog No.:BCN1061
CAS No.:485-72-3
- Hydrangetin
Catalog No.:BCN7439
CAS No.:485-90-5
- 5,7,3'-Trihydroxyflavanone
Catalog No.:BCC8269
CAS No.:104732-07-2
- Proanthocyanidins
Catalog No.:BCN6313
CAS No.:4852-22-6
- Choline sulphate
Catalog No.:BCN1792
CAS No.:4858-96-2
- Mirabijalone D
Catalog No.:BCN4071
CAS No.:485811-84-5
- PMX 464
Catalog No.:BCC6348
CAS No.:485842-97-5
- Isofraxidin
Catalog No.:BCN2327
CAS No.:486-21-5
- Fraxinol
Catalog No.:BCN5584
CAS No.:486-28-2
- Daphnetin
Catalog No.:BCN1051
CAS No.:486-35-1
- (S)-Coclaurine
Catalog No.:BCN5585
CAS No.:486-39-5
- (-)-Cotinine
Catalog No.:BCC7569
CAS No.:486-56-6
Chiral modification of copper exchanged zeolite-Y with cinchonidine and its application in the asymmetric Henry reaction.[Pubmed:26579982]
Dalton Trans. 2015 Dec 28;44(48):20949-63.
Chirally modified Cu(2+) exchanged zeolite-Y was synthesized by direct adsorption of Cinchonidine under ambient conditions. The chirally modified materials were characterized using various spectrochemical and physicochemical techniques viz. BET, FTIR, MAS ((1)H and (13)C NMR), XPS, SEM, cyclic voltammetry and PXRD. Characteristic peaks of Cinchonidine observed in the supported materials confirmed the adsorption of Cinchonidine and its coordination with the Cu(2+) active site on copper exchanged zeolite-Y. (13)C SSNMR and XPS analysis however confirmed for the half encapsulation process, only the quinoline ring of Cinchonidine gets coordinated to the internal metal sites via the N atom while the quinuclidine moiety extends out of the host surface. Cinchonidine supported Cu(2+)-Y zeolites were found to exhibit good catalytic performance in the asymmetric Henry reaction. (1)H SSNMR studies also confirmed the protonation of the N atom of the quinuclidine ring during the course of the Henry reaction. Heterogeneous chiral catalysts were effective for up to two consecutive cycles. Leaching of Cinchonidine after the second cycle was found to have a negative result in the catalytic performance.
Exotic Protonated Species Produced by UV-Induced Photofragmentation of a Protonated Dimer: Metastable Protonated Cinchonidine.[Pubmed:26347997]
J Phys Chem A. 2015 Oct 1;119(39):10007-15.
A metastable protonated cinchona alkaloid was produced in the gas phase by UV-induced photodissociation (UVPD) of its protonated dimer in a Paul ion trap. The infrared multiple photon dissociation (IRMPD) spectrum of the molecular ion formed by UVPD was obtained and compared to DFT calculations to characterize its structure. The protonation site obtained thereby is not accessible by classical protonation ways. The protonated monomer directly formed in the ESI source or by collision-induced dissociation (CID) of the dimer undergoes protonation at the most basic alkaloid nitrogen. In contrast, protonation occurs at the quinoline aromatic ring nitrogen in the UVPD-formed monomer.
Influences of urea and pH on the interaction of cinchonidine with bovine serum albumin by steady state fluorescence spectroscopy.[Pubmed:23651774]
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Aug;112:15-20.
The binding of Cinchonidine to bovine serum albumin (BSA) in aqueous solution in the absence and presence of urea has been studied by fluorescence spectroscopic techniques at pH 7.40. Denaturation of BSA in the presence of urea is almost complete at [urea] >/=8.0 M. Upon unfolding, two fluorescence peaks of BSA were observed. One peak was assigned to the fluorescence of Trp residue in a polar environment, and the other peak was assigned to the fluorescence of Tyr residues. In addition, the fluorescence quenching effects of Cinchonidine were shown not only on the native but also on the unfolded form of BSA. The quenching rate constants and binding constants calculated in the absence and presence of the denaturant urea indicates that the binding capacity of Cinchonidine to the denatured BSA deceases dramatically. In addition, influence of pH on the interaction between Cinchonidine and BSA was investigated and the binding abilities of the drug to BSA deceased under lower pH conditions (pH 3.5 and 1.8) and higher pH conditions (pH 9.0).
Chiral modification of platinum by co-adsorbed cinchonidine and trifluoroacetic acid: origin of enhanced stereocontrol in the hydrogenation of trifluoroacetophenone.[Pubmed:24382788]
Chemistry. 2014 Jan 27;20(5):1298-309.
Cinchonidine (CD) adsorbed onto a platinum metal catalyst leads to rate acceleration and induces strong stereocontrol in the asymmetric hydrogenation of trifluoroacetophenone. Addition of catalytic amounts of trifluoroacetic acid (TFA) significantly enhances the enantiomeric excess from 50 to 92%. The origin of the enantioselectivity bestowed by co-adsorbed CD and TFA is investigated by using in situ attenuated total reflection infrared spectroscopy and modulation excitation spectroscopy. Molecular interactions between the chiral modifier (CD), acid additive (TFA) and the trifluoro-activated substrate at the solid-liquid interface are elucidated under conditions relevant to catalytic hydrogenations, that is, on a technical Pt/Al2O3 catalyst in the presence of H2 and solvent. Monitoring of the unmodified and modified surface during the hydrogenation provides an insight into the phenomenon of rate enhancement and the crucial interactions of CD with the ketone, corresponding product alcohol, and TFA. Comparison of the diastereomeric interactions occurring on the modified surface and in the liquid solution shows a striking difference for the chiral preferences of CD. The spectroscopic data, in combination with calculations of molecular structures and energies, sheds light on the reaction mechanism of the heterogeneous asymmetric hydrogenation of trifluoromethyl ketones and the involvement of TFA in the diastereomeric intermediate surface complex: the quinuclidine N atom of the adsorbed CD forms an N-H-O-type hydrogen-bonding interaction not only with the trifluoro-activated ketone but also with the corresponding alcohol and the acid additive. Strong evidence is provided that it is a monodentate acid/base adduct in which the carboxylate of TFA resides at the quinuclidine N-atom of CD, which imparts a better stereochemical control.